Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

MaxDiscovery™ Mouse Granzyme B ELISA Test Kit

Product Description
The MaxDiscovery™ Mouse Granzyme B ELISA Test Kit is designed for quantitative determination of the concentration of mouse granzyme B in serum, plasma, and cell culture supernatant. Mouse granzyme B is a ~25 kDa protein of 227 amino acids (aa) after cleavage of a 20 aa signal peptide. It is a member of the Granzyme family of exogenous serine proteases and is one of the eleven Granzymes (A,B,C,D,E,F,G,K,M,N,O) found in the mouse genome. Granzymes are released by cytoplasmic granules within cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Their purpose is to induce apoptosis within virus-infected tumorigenic cells, thus destroying them. Granzyme B works in conjunction with the protein perforin to induce apoptosis in target cells by forming transmembrane pores and through cleavage of effector caspases such as caspase-3. A caspase-independent mechanism of granzyme B-mediated apoptosis has also been suggested. Granzyme B may have roles in rheumatoid arthritis and in bacterial and viral infections. Measuring granzyme B release in response to the appropriate target is useful for evaluating cell-mediated cytotoxicity.
Product MaxDiscovery™ Mouse Granzyme B ELISA Test Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 2014-01
Quantity 1 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122

Scientific News
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
A Better Model for Parkinson's
Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Microalgae Make a Splash in the UK Cosmeceutical Market
Scottish innovators have discovered an anti-viral and anti-inflammatory carbohydrate in microscopic algae (microalgae) which has huge potential to change the cosmetics market.
Mechanism of Tumor Suppressing Gene Uncovered
The most commonly mutated gene in cancer,p53, works to prevent tumor formation by keeping mobile elements in check that otherwise lead to genomic instability, UT Southwestern Medical Center researchers have found.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
Useful Colon Cancer Biomarker Discovered
Biomarker is detectable with simple, inexpensive test.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Seeing Hope
Gene therapy/drug combo restores some vision in mice with optic nerve injury.
Versatile New Molecule-Building Technique
Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos